Terns Pharmaceuticals Inc... (TERN)
NASDAQ: TERN
· Real-Time Price · USD
7.07
0.30 (4.43%)
At close: Aug 15, 2025, 3:59 PM
7.12
0.78%
After-hours: Aug 15, 2025, 06:54 PM EDT
Terns Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 1.32M | 1.32M | 1.32M | 1.32M | n/a | n/a | n/a | n/a | 1M | 1M | 1M | 1M | n/a | n/a | n/a |
Cost of Revenue | 108K | 240K | 476K | 696K | 918K | 895K | 881K | 1.15M | 1.18M | 1.23M | 1.28M | 913K | 768K | 618K | 512K | 398K | 291K | 172K |
Gross Profit | -108K | -240K | -476K | 626K | 404K | 427K | 441K | -1.15M | -1.18M | -1.23M | -1.28M | 87K | 232K | 382K | 488K | -398K | -291K | -172K |
Operating Income | -105.7M | -103.85M | -101.87M | -99.98M | -108.22M | -103.85M | -102.56M | -95.33M | -79.44M | -72.36M | -62.03M | -59.08M | -53.66M | -50.39M | -49.86M | -44.75M | -41.62M | -40.9M |
Interest Income | 14.22M | 13.75M | 13.29M | 12.48M | 12.87M | 13.39M | 12.9M | 10.9M | 7.92M | 4.73M | 2.11M | 837K | 387K | 228K | 170K | 117K | 69K | 16K |
Pretax Income | -91.49M | -90.14M | -88.59M | -87.8M | -95.63M | -90.78M | -89.97M | -84.5M | -71.6M | -67.7M | -59.99M | -58.3M | -53.3M | -50.1M | -49.65M | -45.05M | -44.73M | -43.85M |
Net Income | -91.75M | -90.39M | -88.85M | -88.07M | -95.89M | -91.06M | -90.21M | -85.01M | -72.07M | -68.1M | -60.34M | -58.77M | -53.79M | -50.59M | -50.16M | -45.84M | -45.44M | -44.39M |
Selling & General & Admin | 33.34M | 33.61M | 31.52M | 29.96M | 38.54M | 38.36M | 38.84M | 38.63M | 25.41M | 23.82M | 22.41M | 21.66M | 21.24M | 20.68M | 19.55M | 15.13M | 13.75M | 11.38M |
Research & Development | 72.25M | 70.25M | 70.11M | 69.57M | 69.23M | 65.03M | 63.5M | 56.7M | 54.03M | 48.54M | 39.62M | 38.42M | 33.41M | 30.71M | 31.31M | 29.62M | 27.87M | 29.52M |
Other Expenses | n/a | n/a | -12K | -12K | -17K | -77K | -69K | -73K | -82K | -76K | -68K | -54K | -36K | 57K | 40K | 30K | 26K | -13K |
Operating Expenses | 105.59M | 103.85M | 101.64M | 99.52M | 107.77M | 103.39M | 102.34M | 95.33M | 79.44M | 72.36M | 62.03M | 60.08M | 54.66M | 51.39M | 50.86M | 44.75M | 41.62M | 40.9M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -236K | -456K | -456K | -456K | -220K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 105.7M | 103.85M | 101.87M | 99.98M | 108.22M | 103.85M | 102.56M | 95.33M | 79.44M | 72.36M | 62.03M | 60.08M | 54.66M | 51.39M | 50.86M | 44.75M | 41.62M | 40.9M |
Income Tax Expense | 78K | 75K | 260K | 269K | 265K | 276K | 239K | 508K | 463K | 397K | 358K | 475K | 482K | 490K | 508K | 784K | 866K | 852K |
Shares Outstanding (Basic) | 91.58M | 91.47M | 91.24M | 77.82M | 74.46M | 74.4M | 72.33M | 71.53M | 71.36M | 69.78M | 54.7M | 38.51M | 25.3M | 25.27M | 25.27M | 25.15M | 25.11M | 15.16M |
Shares Outstanding (Diluted) | 91.58M | 91.47M | 91.24M | 77.82M | 74.46M | 74.4M | 72.33M | 71.53M | 71.36M | 69.78M | 54.7M | 38.51M | 25.3M | 25.27M | 25.27M | 25.15M | 25.11M | 15.16M |
EPS (Basic) | -1.04 | -1.09 | -1.13 | -1.18 | -1.32 | -1.26 | -1.27 | -1.27 | -1.29 | -1.59 | -1.83 | -2.1 | -2.13 | -2.01 | -2.34 | -2.43 | -2.44 | -2.41 |
EPS (Diluted) | -1.04 | -1.09 | -1.13 | -1.18 | -1.32 | -1.26 | -1.27 | -1.27 | -1.29 | -1.59 | -1.83 | -2.1 | -2.13 | -2.01 | -2.34 | -2.43 | -2.44 | -2.41 |
EBITDA | -101.82M | -103.19M | -101.13M | -99.38M | -107.76M | -103.62M | -102.41M | -95.01M | -78.94M | -71.6M | -60.91M | -58.09M | -52.81M | -49.7M | -49.35M | -44.25M | -41.12M | -40.42M |
EBIT | -102.34M | -103.85M | -101.87M | -99.98M | -108.22M | -103.85M | -102.56M | -95.33M | -79.44M | -72.36M | -62.03M | -59.08M | -53.66M | -50.39M | -49.86M | -44.75M | -41.62M | -40.9M |
Depreciation & Amortization | 697K | 829K | 896K | 902K | 918K | 895K | 881K | 1.15M | 1.18M | 1.23M | 1.28M | 913K | 768K | 618K | 512K | 504K | 498K | 478K |